Clinical Trials Directory

Trials / Terminated

TerminatedNCT02008539

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
13 (actual)
Sponsor
Apceth GmbH & Co. KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and tolerability of MSC\_apceth\_101.

Conditions

Interventions

TypeNameDescription
DRUGMSC_apceth_101

Timeline

Start date
2013-10-01
Primary completion
2016-09-07
Completion
2016-09-07
First posted
2013-12-11
Last updated
2017-03-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02008539. Inclusion in this directory is not an endorsement.

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101 (NCT02008539) · Clinical Trials Directory